PATENT CLAIM ANALYSIS

Application Number: 16364121
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-10
Patent Classification: ["514", "728000"]

Abstract:
Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof and insulin or an insulin analogue in the treatment of mellitus and/or disorders related to diabetes mellitus.

Claim (Index 9):
The pharmaceutical composition of  claim 8 , wherein the insulin analogue is glargine.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15957956', '15597200', '16179896', '15827121', '14326075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7179744902452363
- 35 USC 102 Novelty (BERT): 0.5394468029835703
- Combined Prediction Score: 0.7001217215190698
- Mean Citation Score: 301.682604
- Max Citation Score: 339.66556
- Similarity Product: 181.64226721191883

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test